Remove 2023 Remove Complication Remove Individual Remove Patient-Centered
article thumbnail

Natural History of Asymptomatic Renal Stones Before RC

Physician's Weekly

They reviewed individuals referred for RC and UD between 2015 and 2023 at a single center. Individuals with prior stone interventions, additional ureteric stones, or no postoperative imaging were excluded. Preoperative CT scans were analyzed to identify those with asymptomatic renal stones. The mean stone burden was 4.5

article thumbnail

Have Job-Based Health Coverage at 65? You May Still Want To Sign Up for Medicare

Physician's Weekly

When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. The Centers for Medicare & Medicaid Services did not respond to a request for comment. The bills totaled more than $100,000.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Parvo Podcast! Erythema Infectiosum, Fifth Disease, and more!

PEMBlog

Well break down the virology, epidemiology, clinical presentation, and complications of Parvovirus B19. Formulate an evidence-based management plan for patients with suspected or confirmed Parvovirus B19, including those with underlying hemolytic disease or immunocompromise. Centers for Disease Control and Prevention.

article thumbnail

A prophylactic treatment for hemophilia that you should know about

PEMBlog

A special thanks to Dr. Cristina Tarango, director of the Hemophilia Treatment Center at Cincinnati Children’s and Lisa Littner, Project Manager at Cincinnati Children’s who helped me research and write this post. How to know if a patient is on it? Patients on emicizumab will have it listed on their medication list.

article thumbnail

FDA Creates a New Advisory Committee for Genetic Metabolic Diseases – Could This Be an Opportunity to Support Rare Disease Product Development More Broadly?

FDA Law

Sasinowski — On December 12, 2023, FDA announced the creation of a new advisory committee specifically for treatments for genetic metabolic diseases, the Genetic Metabolic Diseases Advisory Committee, or “GeMDAC.” Drug development for these conditions has unique and complex challenges, therefore few treatments are available to patients.”

article thumbnail

A Podcast on Inhalant Misuse: From Glue to Galaxy Gas

PEMBlog

Formulate effective strategies for identifying, managing, and preventing inhalant misuse in pediatric patients. Inhalant misuse reported to Americas Poison Centers, 2001-2021. Clin Toxicol (Phila) 2023; 61:453. Patients that use these will repeatedly use it throughout the day. References Perry H, Burns MM. Intelligencer.

article thumbnail

The Nature of Suffering: BJ Miller and Naomi Saks

GeriPal

2023 Dec 20:S1524-9042(23)00202-3. I think even the word patient, patient, I think, comes from the word suffer, the one who suffers. More of the point is we get in big trouble with ourselves and with our patients and each other if we go down that comparison track too far, I think that we can cause some real trouble there.

IT 137